Advertisement

Topics

Latest "World Hepatitis Alliance" News Stories

03:02 EDT 20th October 2017 | BioPortfolio

Here are the most relevant search results for "World Hepatitis Alliance" found in our extensive news archives from over 250 global news sources.

More Information about World Hepatitis Alliance on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about World Hepatitis Alliance for you to read. Along with our medical data and news we also list World Hepatitis Alliance Clinical Trials, which are updated daily. BioPortfolio also has a large database of World Hepatitis Alliance Companies for you to search.

Showing "World Hepatitis Alliance" News Articles 1–25 of 10,000+

Extremely Relevant

World Hepatitis Day sets the stage for the elimination of viral hepatitis

(World Hepatitis Alliance) Today, World Hepatitis Day, marks the first time that the global health community has come together to officially begin moving towards the elimination of viral hepatitis by 2030.


World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030

July 28th is marked as world hepatitis day. The world is united in elimination of viral hepatitis by 2030. The World Health Organization (WHO) has published new data from 28 countries today and shown that nearly 70% of the world hepatitis burden is borne by these countries.

Eliminate hepatitis: WHO

New WHO data from 28 countries - representing approximately 70% of the global hepatitis burden - indicate that efforts to eliminate hepatitis are gaining momentum. Published to coincide with World Hepatitis Day, the data reveal that nearly all 28 countries have established high-level national hepatitis elimination committees (with plans and targets in place) and more than half have allocated ded...


Relevant

Nine in 10 people unaware they have hepatitis

The WHO has released a report on the state of hepatitis prevention and treatment to mark World Hepatitis Day, with an emphasis that much work is left to be done to combat the viral infection. The organisation called for national responses towards hepatitis elimination to be accelerated and suggested that, at best, only one in 10 people were aware that they had the illness. In further cause of con...

Around 9 million Europeans are affected by chronic hepatitis B or C

An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million (3.9) with chronic hepatitis C infection. However, large numbers of them are not even aware of their infection as they have not yet been tested and diagnosed. On the occasion of World Hepatitis Day on 28 July, ECDC Director Andrea Ammon highlights the need for Europe to scale-up coverage of testing, prevent...

Hepatitis C has a cure — now insurers just need to pay for it

Today is World Hepatitis Day. In The Hill newspaper, BIO CEO Jim Greenwood argues that ...

Hepatitis drugs more affordable but disease still deadly: WHO

GENEVA (Reuters) - Prices of drugs to cure hepatitis C and to treat hepatitis B are dropping dramatically, offering affordability and hope to 325 million people living with the viral liver disease that can be fatal, the World Health Organisation (WHO...

ECDC estimate: Around 9 million Europeans are affected by chronic hepatitis B or C

(European Centre for Disease Prevention and Control (ECDC) ) An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million with chronic hepatitis C infection. But large numbers of them are not aware of their infection as they have not yet been diagnosed. On of World Hepatitis Day, ECDC Director Andrea Ammon highlights the need for Europe to scale-up coverage of testi...

Japan Approves 8-Week Treatment for Genotype 1 and 2 Hepatitis C Virus

NewsEnanta announces that AbbVie’s Maviret glecaprevir/pibrentasvir received approval in Japan for the treatment of all major genotypes (GT1-6) of chronic hepatitis C. Japan has one of the highest rates of hepatitis C virus infection in the industrialized world.

New research shows indigenous peoples are much more likely to be infected by hepatitis B and/or C

A new meta-analysis of global hepatitis data—presented at this year's World Indigenous Peoples' Conference on Viral Hepatitis in Anchorage, Alaska, USA (8-9 August)—shows that Indigenous Peoples are up to 10 times more likely to be infected by viral hepatitis than the general population in their respective countries. The analysis is presented by Dr Homie Razavi and Devin Razavi-Shearer, The Po...

Study shows universal vaccination has wiped out hepatitis B and associated liver cancer in Alaska's young people

Updated research presented at this year's World Indigenous Peoples' Conference on Viral Hepatitis in Anchorage, Alaska, USA (8-9 August) shows that the universal hepatitis B vaccination programme introduced for all newborn Alaskan children in the 1980s has wiped out hepatitis B infection and liver cancer cases associated with the infection. The study is by Dr Brian McMahon, Director of the Alaska ...

Scientists notice shift in transmission mechanism of HEV infections

Hepatitis E gets little press compared to its better-known cousins A, B, and C, but Stellenbosch University virologists say we should wake up to how transmission of this virus is changing. World Hepatitis Day is commemorated on 28 July.

From chronic to cured—could Australia be the first to eliminate hep C?

Australia is on track to eliminate hepatitis C by 2026, a new report released by the Kirby Institute on World Hepatitis Day shows.

WHO prequalifies first generic hepatitis C drug

The World Health Organization (WHO) has pre-qualified the first generic drug to treat hepatitis C. The antiviral agent sofosbuvir will be manufactured at a lower cost by Mylan.

Cherokee Nation American Indian Tribe showing it is possible to eliminate hepatitis C

The Cherokee Nation American Indian population is aiming to eliminate hepatitis C virus (HCV) among its tribal citizens, where already almost half have been screened for the virus and around one quarter of those estimated to be infected have already been cured. The tribe will present its progress at the World Indigenous People's Conference on Viral Hepatitis in Anchorage, Alaska (August 8-9).

People who use drugs require prioritization, not exclusion, in HCV elimination

An international conference bringing together hepatitis C experts from around the world is today calling for strategies to prioritise people who use drugs, saying hepatitis C elimination is impossible without them.

Medical News Today: How is hepatitis C transmitted?

In this article, learn about how hepatitis C is transmitted, the types of hepatitis, their symptoms, and how to prevent transmission of the virus.

UK adds hepatitis B to infant vaccination schedule

Hepatitis B vaccine is being introduced for newborns from the autumn in the UK, making it one of the last countries in Europe to introduce a universal hepatitis B vaccination programme for...

Pacific Alliance explores single passport for member nations

The Pacific Alliance trade group will explore whether to create a single passport for its four member nations in a bid to encourage tourism and trade across the world, Colombia's migration director said on Thursday. The alliance, which comprises Colombia, Chile, Mexico and Peru and was formed in April 20

Hepatitis B vaccine shortage: another symptom of chronic neglect?

Current shortages of the hepatitis B virus vaccine have created media interest, including in The BMJ.1 Hepatitis B should make headlines; an estimated 250 million people are chronically infected, and...

Hepatitis Barriers to Care Focus of ICVH 2017

Efforts to improve screening for hepatitis C and access to treatment, especially for high-risk populations, will be in the spotlight at the upcoming International Conference on Viral Hepatitis (ICVH). Medscape Medical News

ECDC highlights need to scale-up efforts for eliminating viral hepatitis in Europe

An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million (3.9) with chronic hepatitis C infection.

Johnson & Johnson: The Fundamentals of Alliance Management

Johnson & Johnson were one of the first companies to realise the importance of an alliance management group closely following in rival Eli Lilly & Co.’s footsteps. Rob Wills, VP Alliance Management at Johnson & Johnson, returned to the show to talk about how deal structures have evolved and the difficulties of measuring success in the alliance management arena.

CSE: 2017-0918 - Suspension - Alliance Growers Corp. (ACG)

TORONTO, ONTARIO -- (Marketwired) -- 09/29/17 -- Alliance Growers Corp. is in default of CSE requirements. Effective immediately, Alliance Growers will be suspended pursuant to CSE Policy 3. The s...

AstraZeneca: Rob Hockney, Director of Alliance Management, Global Discovery Alliances

Rob Hockney talks to Fintan Walton about the ongoing evolution of AstraZeneca's alliance management strategy and capabilities, and the increasingly important role that dedicated alliance management plays in the drug development process for big pharma and small biotech companies alike. Rob emphasises the need for flexibility when developing an alliance management strategy and the importance of dial...


Quick Search
Advertisement
 

News Quicklinks